Boston Scientific’s Farapulse matches Medtronic cryoablation in trial
Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.
MedTech Dive3d
3 takeaways from ACC 2025
Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.
FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout
The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.
TCTMD5d
Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF
The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.
MassDevice5d
Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system
Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...